Opportunity Information: Apply for PAR 22 180
The Maximizing Investigators' Research Award (MIRA) is an NIH grant opportunity run through the National Institute of General Medical Sciences (NIGMS) that supports an investigator's overall research program rather than a single narrowly defined project. It is offered under the R35 mechanism and is listed as "Clinical Trial Optional," meaning clinical trials may be included if they fit the NIGMS mission, but they are not required. The central idea is to fund the body of work happening in an investigator's lab that aligns with NIGMS priorities, giving the investigator room to pursue important questions as the science evolves.
A major purpose of MIRA is to make NIGMS funding work better for both researchers and the broader scientific enterprise. The program is designed to increase funding stability for NIGMS-supported investigators, which can make it easier to plan multi-year, ambitious research efforts and take on higher-risk, higher-reward directions. It also aims to increase flexibility by reducing how tightly investigators are locked into specific aims written far in advance, so they can pivot when new findings, new methods, or unexpected opportunities arise within the NIGMS mission. At a system level, MIRA is also intended to distribute funding more broadly across a larger number of talented investigators, with the goal of improving overall scientific productivity and increasing the likelihood of major breakthroughs by supporting a wider range of ideas and approaches.
Another explicit goal is to cut down on the time burden associated with repeatedly writing, submitting, and reviewing multiple grant applications. By consolidating support into a program-level award, MIRA is meant to reduce administrative churn and free investigators to spend more time actually doing research. The FOA also highlights mentoring as a key benefit: a steadier funding environment can allow a principal investigator to invest more consistently in training and mentorship for students and postdocs, rather than constantly operating in short funding cycles.
This funding opportunity allows applications from eligible investigators who are already NIGMS-funded as well as from New Investigators proposing research that fits within the NIGMS scientific mission. It also accepts renewal applications from current MIRA grantees, including established investigators and those who were originally funded as early-stage investigators. One important eligibility boundary is that current Early Stage Investigators (ESIs) are directed not to apply through this specific FOA; instead, they are expected to apply through the separate ESI MIRA funding opportunity.
On the organizational side, eligibility is broad across many common U.S. applicant types. The opportunity lists eligibility for a range of government entities (state, county, city or township governments, special district governments), educational institutions (public and state-controlled universities, private institutions of higher education, and independent school districts), tribal entities (federally recognized Native American tribal governments and other Native American tribal organizations), and housing authorities (public housing authorities and Indian housing authorities). It also includes nonprofits (both 501(c)(3) and non-501(c)(3), other than institutions of higher education), for-profit organizations (other than small businesses), and small businesses. The FOA also calls out categories of institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies.
There are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as applicants. However, foreign components are allowed when they meet the NIH definition in the NIH Grants Policy Statement, which typically means a U.S.-based applicant can include certain justified foreign elements of the research as part of the overall project structure, even though a foreign institution cannot be the main applicant.
Key listing details from the source include the Funding Opportunity Title "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)," Funding Opportunity Number PAR-22-180, and Agency Name National Institutes of Health. The opportunity is categorized as discretionary and uses the grant funding instrument, with a health activity category and CFDA number 93.859. The original closing date provided is 2025-05-16. The source also lists an award ceiling of 250000, indicating an upper bound noted in the listing for award amount, though actual budgets and project periods in NIH awards are typically governed by NIH and institute-specific policies and the applicant's justified needs as reviewed and negotiated.Apply for PAR 22 180
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2022-05-24.
- Applicants must submit their applications by 2025-05-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
Previous opportunity: Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 22 180
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 22 180) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) Apply for PAR 22 172 Funding Number: PAR 22 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) Apply for RFA NS 22 067 Funding Number: RFA NS 22 067 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed) Apply for RFA RM 22 022 Funding Number: RFA RM 22 022 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) Apply for PAR 22 155 Funding Number: PAR 22 155 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed) Apply for RFA RM 22 023 Funding Number: RFA RM 22 023 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) Apply for PAR 22 185 Funding Number: PAR 22 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) Apply for PAR 22 194 Funding Number: PAR 22 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) Apply for RFA NS 22 051 Funding Number: RFA NS 22 051 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 023 Funding Number: RFA AG 23 023 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 022 Funding Number: RFA AG 23 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required) Apply for RFA NS 23 001 Funding Number: RFA NS 23 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Apply for PAS 22 196 Funding Number: PAS 22 196 Agency: National Institutes of Health Category: Health Funding Amount: $1,838,436 |
| Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) Apply for PAS 22 197 Funding Number: PAS 22 197 Agency: National Institutes of Health Category: Health Funding Amount: $1,838,436 |
| Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 23 033 Funding Number: RFA AG 23 033 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed) Apply for PAR 22 208 Funding Number: PAR 22 208 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 050 Funding Number: RFA AI 22 050 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) Apply for RFA TR 22 030 Funding Number: RFA TR 22 030 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required) Apply for RFA DE 23 009 Funding Number: RFA DE 23 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) Apply for RFA AG 23 017 Funding Number: RFA AG 23 017 Agency: National Institutes of Health Category: Health Funding Amount: $925,000 |
| Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) Apply for PAR 22 211 Funding Number: PAR 22 211 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 180", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
